27 August 2020 |

The Group keeps on growing, unlike the Italian market

vendite sideral in crescita

The IQVIA figures for the first half of 2020 confirm the stability of PharmaNutra leadership in the nutritional supplements sector. Sales of SiderAL® products are still growing, with a significant increase in market share.


PharmaNutra S.p.A. carries on collecting important commercial acknowledgements.

Despite the fact that globally in the first six months of 2020, the iron supplements’ market dropped slightly compared to the same period the previous year (-0.5%), SiderAL® brand product sales grew 3.2% in that same period, increasing their market share considerably. This went from 43.2% in the first half of 2019 to 44.8% in 2020, reaching 45.5% in the second quarter of this year.


In an especially complex historical and economic moment, the SiderAL® range further strengthens its food supplements sector leadership, as shown by the latest IQVIA1 market figures formalised in the June 2020 monthly report by FederSalus. SiderAL® Forte 20 capsules, nutritional supplement based on Sucrosomial® Iron and Vitamin C, is confirmed as the product sold most on the market in the first half of 2020. Leadership consolidated by year on year growth of 6.1% (MAT values) and 4.9% (YTD values).


Extremely positive figures which, despite the overall sector drop, confirm both the stability and the important position reached by the Company founded in 2003 by the Lacorte brothers. In the first half of 2020, the food supplements market achieved a value of about €1.8 billion, for a total of 130 million packets sold showing a -2.2% in value and a -3.5% in units compared to the same period in 2019. At June 2020, compared to June 2019, the market dropped and reported an -8.3% in value and a -9.5% in sales volume terms.


“The fact that SiderAL® Forte 20 capsules is the number one reference for the Italian food supplements market is an umpteenth confirmation of how effective our Sucrosomial® Technology is; it reduces problems usually associated with other types of iron, but that’s not all”, declares the President of PharmaNutra S.p.A. Andrea Lacorte. “At this point, we can easily talk of leadership stability and I do not just mean the oral iron one where SiderAL® has been registering record numbers for some time, but for food supplements in general. A market which, in Italy alone, can boast a €3 billion turnover, despite the difficult economic period caused by the COVID-19 pandemic”.


1 The figures refer to the total of distribution channels (source IQVIA).